Mouse Anti-Human Complement Factor I Monoclonal Antibody (CTJS-340)(Cat#: CTA-068)
This product is an unconjugated anti-Human Complement Factor I Monoclonal antibody (CTJS-340) generated from the Mouse. The antibody can be used for FC; IP; IHC; WB.
Summary
Related Products & Services
Specifications
| Clonality |
Monoclonal |
| Clone |
CTJS-340 |
| Host Animal |
Mouse |
| Isotype |
IgG1κ |
| Immunogen |
Factor I isolated from human plasma adsorbed onto aluminum hydroxide gel |
| Species Reactivity |
Human |
| Applications |
FC; IP; IHC; WB |
| Application Notes |
FC: 1:200
IP: 5 µg/mL
WB: 1:500 - 1:1000
The optimal working dilutions should be determined by the end user. |
| Specificity |
This antibody reacts with Human complement Factor I. |
| Purity |
≥95% as determined by SDS-PAGE |
| Format |
Liquid |
| Size |
100 µg |
| Storage |
4°C |
| Type |
Primary Antibody |
Target
| Target Name |
Factor I |
| Alternative Names |
Konglutinogen-Activating Factor; C3B/C4B Inactivator; C3b-Inactivator; Complement Control Protein Factor I; Complement Factor I Heavy Chain; Light Chain Of Factor I; Complement Component I; I Factor (Complement); EC 3.4.21.45; FI; IF; KAF; AHUS3; ARMD13; C3BINA; C3b-INA |
| Gene ID |
3426 |
| UniProt ID |
P05156 |
Information
| Introduction |
Complement factor I, also known as C3b/C4b inactivator, is a protein that in humans is encoded by the CFI gene. Complement factor I (factor I) is a protein of the complement system, first isolated in 1966 in guinea pig serum, that regulates complement activation by cleaving cell-bound or fluid phase C3b and C4b. It is a soluble glycoprotein that circulates in human blood at an average concentration of 35 μg/mL. |
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
